Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
53 pending office actions • 27 clients • 51 examiners • 29 art units • 0 of 53 (0%) have an AI response strategy ready
WOLTER VAN DYKE DAVIS, PLLC focuses on Biotechnology & Pharmaceuticals, having handled 3418 career applications. The firm currently manages 35 pending office actions. It has achieved a resolved allowance rate of 85.29 percent, showing a high degree of success in obtaining patent grants for its clients in this field. The firm averages 3.29 office actions per allowance, which indicates a standard prosecution timeline involving several interactions with the USPTO.
This average of 3.29 suggests that the firm effectively manages the examination process to reach the 85.29 percent allowance rate. For practitioners, the 3418 career applications provide a significant data set that supports the firm's reputation for reliability in the biotechnology sector. The 35 pending office actions reflect a steady workload that the firm continues to process using its established methods. By maintaining an average of 3.29 office actions per allowance, the firm demonstrates a consistent ability to overcome rejections and secure the 85.29 percent allowance rate for its clients in the highly technical Biotechnology & Pharmaceuticals area.
Based on the USPTO statutory response window for each pending office action. 18 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 18 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (4%) |
| §101 + other | 5 (9%) |
| §103 only | 11 (21%) |
| §102 only | 3 (6%) |
| §112 only | 6 (11%) |
| Double-patenting + other | 2 (4%) |
| Multi-statute (no §101) | 24 (45%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LI, CHANGQING | 2 | 29.3% | +33.6% |
| ROBINSON, HOPE A | 2 | 67.7% | +43.1% |
| ZHONG, WAYNESHAOBIN | 1 | 72.2% | +21.5% |
| AURORA, REENA | 1 | 87.1% | -13.4% |
| RUSHING, MARK S | 1 | 76.7% | +23.6% |
| TIWARI, VYOMA SHUBHAM | 1 | 31.5% | +48.1% |
| FARDANESH, MARJAN | 1 | 72.6% | +18.9% |
| WEHRHEIM, LINDSEY GAIL | 1 | 78.8% | +19.7% |
| HULL, JAMES B | 1 | 45.4% | +52.4% |
| WHITE, DAWANNA SHAR-DAY | 1 | 62.5% | +23.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18998662 | SINGLE CRYSTAL SAPPHIRE COMPONENT FOR ANGULAR CONTROL DURING SOLID STATE NUCLEAR MAGNETIC RESONANCE MEASUREMENTS | AURORA, REENA | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18178192 | AGENTS FOR THE TREATMENT OF DISEASES BY INHIBITION OF FOXO1 | FETTEROLF, BRANDON J | 56d overdue |
| 18021884 | USE OF FANA ANTISENSE OLIGONUCLEOTIDES FOR THE PREVENTION AND MANAGEMENT OF HUANGLONGBING AND ZEBRA CHIP DISEASES | CHATTERJEE, JAYANTA | 53d overdue |
| 18709666 | SYSTEMS AND METHODS TO IMPROVE PATIENT SELF-ADMINISTRATION | EGLOFF, PETER RICHARD | 35d overdue |
| 17370759 | IDENTIFYING TRANSITION POINTS IN CHEMICAL REACTIONS | MINCHELLA, KAITLYN L | 1d overdue |
| 18272339 | NOZZLE BLOCK HAVING CLEANING MEANS, AND ELECTROSPINNING DEVICE HAVING SAME | WOO, JONATHAN BRIAN | 8d |
| 17432177 | LIF THERAPY FOR INDUCING INTESTINAL EPITHELIAL CELL REGENERATION | XIE, XIAOZHEN | 12d |
| 17818159 | XANTHINE OXIDASE INHIBITOR FORMULATIONS | HUANG, GIGI GEORGIANA | 14d |
| 18252069 | METHOD OF SENSITIZING CANCERS TO IMMUNOTHERAPY USING IMMUNOMODULATORY AGENTS | REYNOLDS, FRED H | 16d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18715258 | ENERGY HARVESTING SUBSTANCE EVENT MONITORING SYSTEM | RUSHING, MARK S | 26d |
| 18539597 | PREBIOTIC FORMULATIONS | LI, CHANGQING | 26d |
| 19220933 | METHODS AND COMPOSITIONS FOR PLANT PATHOGEN RESISTANCE IN PLANTS | ZHONG, WAYNESHAOBIN | — |
| 18870030 | CELL-FREE DNA CONCENTRATION IN HYPOTHERMIC MACHINE PERFUSATE AS A RAPID MARKER FOR KIDNEY GRAFT QUALITY | TIWARI, VYOMA SHUBHAM | — |
| 18869522 | TECHNIQUES FOR MEASURING ATYPICAL NEURODEVELOPMENT IN NEONATES BASED ON AUDITORY BRAINSTEM RESPONSE (ABR) TESTS | FARDANESH, MARJAN | — |
| 18865936 | APPARATUS AND METHOD FOR DETERMINING STIMULATION PARAMETERS FOR DEEP BRAIN STIMULATION (DBS) | WEHRHEIM, LINDSEY GAIL | — |
| 18862702 | AR MARKER FOR INJECTION | HULL, JAMES B | — |
| 18857231 | SMALL MOLECULE INDUCERS OF CARDIOMYOCYTES TO IMPROVE CARDIAC STRUCTURE AND FUNCTION | WHITE, DAWANNA SHAR-DAY | — |
| Art Unit | Apps |
|---|---|
| 1662 | 5 |
| 1613 | 3 |
| 1754 | 2 |
| 1656 | 2 |
| 1652 | 2 |
| 1615 | 2 |
| 2689 | 1 |
| 3734 | 1 |
| 1788 | 1 |
| 1793 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19220933 | METHODS AND COMPOSITIONS FOR PLANT PATHOGEN RESISTANCE IN PLANTS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | ZHONG, WAYNESHAOBIN | §112 | Non-Final OA | — | Pending | May 28, 2025 | |
| 18998662 | SINGLE CRYSTAL SAPPHIRE COMPONENT FOR ANGULAR CONTROL DURING SOLID STATE NUCLEAR MAGNETIC RESONANCE MEASUREMENTS | Rutgers, The State University Of New Jersey | AURORA, REENA | §112 | Non-Final OA | — | Pending | Jan 27, 2025 | |
| 18715258 | ENERGY HARVESTING SUBSTANCE EVENT MONITORING SYSTEM | Noble International, LLC | RUSHING, MARK S | 2689 | §103 | Final Rejection | 26d | Pending | Dec 19, 2024 |
| 18870030 | CELL-FREE DNA CONCENTRATION IN HYPOTHERMIC MACHINE PERFUSATE AS A RAPID MARKER FOR KIDNEY GRAFT QUALITY | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | TIWARI, VYOMA SHUBHAM | §103§112 | Non-Final OA | — | Pending | Nov 27, 2024 | |
| 18869522 | TECHNIQUES FOR MEASURING ATYPICAL NEURODEVELOPMENT IN NEONATES BASED ON AUDITORY BRAINSTEM RESPONSE (ABR) TESTS | Rutgers, The State University Of New Jersey | FARDANESH, MARJAN | §103 | Non-Final OA | — | Pending | Nov 26, 2024 | |
| 18865936 | APPARATUS AND METHOD FOR DETERMINING STIMULATION PARAMETERS FOR DEEP BRAIN STIMULATION (DBS) | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | WEHRHEIM, LINDSEY GAIL | §102 | Non-Final OA | — | Pending | Nov 14, 2024 | |
| 18862702 | AR MARKER FOR INJECTION | Noble International, LLC | HULL, JAMES B | §102§103 | Non-Final OA | — | Pending | Nov 04, 2024 | |
| 18857231 | SMALL MOLECULE INDUCERS OF CARDIOMYOCYTES TO IMPROVE CARDIAC STRUCTURE AND FUNCTION | UNIVERSITY OF MARYLAND, BALTIMORE | WHITE, DAWANNA SHAR-DAY | §103§112 | Non-Final OA | — | Pending | Oct 16, 2024 | |
| 18848353 | APPARATUS AND METHOD FOR ATTACHING A HANDS-FREE LENS TO A MICROSCOPE FOR USE DURING OCULAR SURGERY | Oculus Surgical, Inc. | NIGAM, NATASHA | §102§112 | Non-Final OA | — | Pending | Sep 18, 2024 | |
| 18816363 | FIN ARRANGEMENT FOR CANTED TOWER SUPPORT | Roswell U.S. Llc. | VENNE, DANIEL V | §112 | Non-Final OA | — | Pending | Aug 27, 2024 | |
| 18790141 | SMALL MOLECULE INHIBITORS OF GPCR GPR68 AND RELATED RECEPTORS FOR TREATING CANCER, GLIOBLASTOMA, AND OTHER INDICATIONS | UNIVERSITY OF MARYLAND, BALTIMORE | RAO, SAVITHA M | §103DP | Non-Final OA | — | Pending | Jul 31, 2024 | |
| 18832702 | COMPOSITIONS (III) | Symrise AG | LI, CHANGQING | §101§103§112 | Non-Final OA | — | Pending | Jul 24, 2024 | |
| 18777102 | BAG-IN-BOX PACKAGING | DMK DEUTSCHES MILCHKONTOR GMBH | DEMEREE, CHRISTOPHER R | 3734 | §103 | Non-Final OA | 21d | Pending | Jul 18, 2024 |
| 18761250 | DIAGNOSIS AND TREATMENT OF VASODILATORY SHOCK | UNIVERSITY OF MARYLAND, BALTIMORE | VARADARAJ, ARCHANA | §101§102 | Non-Final OA | — | Pending | Jul 01, 2024 | |
| 18720914 | APPARATUS AND METHOD TO PROVIDE A PATHOGENICIDAL BARRIER BETWEEN FIRST AND SECOND REGIONS | X Cell, LLC | THROWER, LARRY W | 1754 | §102§103§112 | Non-Final OA | — | Pending | Jun 17, 2024 |
| 18576480 | ANIONIC EXPLOSION-PROOF MEMBRANE AND PREPARATION METHOD THEREFOR | Hubei Institute Of Aerospace Chemical Technology | DESAI, ANISH P | 1788 | §112 | Non-Final OA | — | Pending | Jun 11, 2024 |
| 18711193 | FRAGRANCES AND FRAGRANCE MIXTURES | Symrise AG | AHVAZI, BIJAN | §103§112 | Non-Final OA | — | Pending | May 17, 2024 | |
| 18665956 | METHOD FOR MANUFACTURING SEMI-HARD CHEESE | DMK DEUTSCHES MILCHKONTOR GMBH | TRAN, LIEN THUY | 1793 | §103§112 | Final Rejection | — | Pending | May 16, 2024 |
| 18709666 | SYSTEMS AND METHODS TO IMPROVE PATIENT SELF-ADMINISTRATION | Noble International, LLC | EGLOFF, PETER RICHARD | 3715 | §101 | Non-Final OA | 35d overdue | Pending | May 13, 2024 |
| 18707248 | Controlling Citrus Huanglongbing (HLB) by Mitigating Cell Death of the Phloem Tissues Caused by Candidatus Liberibacter Asiaticus (CLas) By Suppressing Reactive Oxygen Species (ROS) | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | MEYER, GEORGE WILLIAM | 1662 | §103§112 | Non-Final OA | — | Pending | May 03, 2024 |
| 18706881 | IMPROVED GENETIC TRANSFORMATION BY IMPROVING DE-NOVO SHOOT REGENERATION IN ADULT PLANTS AND DURING IN-VITRO TISSUE CULTURE | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | JOHNSON, EMILY KATHARINE | 1662 | §102§103§112 | Final Rejection | — | Pending | May 02, 2024 |
| 18686633 | RADIATION COMPATIBLE EXPANDER FOR BREAST RECONSTRUCTION | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | FLORES, ADRIAN | 3774 | §102§103 | Non-Final OA | — | Pending | Feb 26, 2024 |
| 18409738 | SIMPLIFIED QUANTITATIVE ANALYSIS USING SUBSTRATES WITH PRE-LOADED STANDARDS | Capitainer AB | HYUN, PAUL SANG HWA | §103§112 | Non-Final OA | — | Pending | Jan 10, 2024 | |
| 18539597 | PREBIOTIC FORMULATIONS | DMK DEUTSCHES MILCHKONTOR GMBH | LI, CHANGQING | 1791 | §102§103 | Final Rejection | 26d | Pending | Dec 14, 2023 |
| 18488234 | BONE DISEASE TREATMENT | The University of Birmingham | ESPINOSA, CLAUDIA EDILMA | 1654 | §102§112 | Non-Final OA | — | Pending | Oct 17, 2023 |
| 18555268 | PORTABLE ULTRASOUND DEVICE FOR IMAGING A SUB-CUTANEOUS STRUCTURE AND METHOD FOR ULTRASONIC IMAGING | Veintech Pty Ltd. | CELESTINE, NYROBI I | 3798 | §103 | Non-Final OA | 11d overdue | Pending | Oct 13, 2023 |
| 18279672 | NOVEL PSEUDOMONAS STRAIN FOR METAL RECOVERY | Brain Biotech AG | STEADMAN, DAVID J | 1656 | §101 | Final Rejection | — | Pending | Aug 31, 2023 |
| 18236078 | PROTEIN-PEG INTERACTIONS THAT REDIRECT THE THERMAL UNFOLDING PATHWAY OF PEGYLATED HUMAN GALECTIN-3C | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | ROBINSON, HOPE A | 1652 | §102§103§112 | Non-Final OA | — | Pending | Aug 21, 2023 |
| 18272339 | NOZZLE BLOCK HAVING CLEANING MEANS, AND ELECTROSPINNING DEVICE HAVING SAME | Jong-Su Park | WOO, JONATHAN BRIAN | 1754 | §103§112 | Final Rejection | 8d | Pending | Jul 13, 2023 |
| 18268280 | CREATE HUANGLONGBING TOLERANCE BY SILENCING A CITRUS NEGATIVE IMMUNE REGULATOR | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | DELEO, VICTORIA LYNN | 1662 | §102§103 | Non-Final OA | — | Pending | Jun 19, 2023 |
| 18038321 | USE OF INSULIN-LIKE GROWTH FACTORS WITH GAMMA-CHAIN CYTOKINES TO INDUCE HOMEOSTATIC PROLIFERATION OF LYMPHOCYTES | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | SULLIVAN, DENNIS JOHN | 1642 | §103 | Non-Final OA | — | Pending | May 23, 2023 |
| 18037364 | MULTIFUNCTION MICROFLUIDIC OPTRODE | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | ROANE, AARON F | 3796 | §102 | Non-Final OA | — | Pending | May 17, 2023 |
| 18252069 | METHOD OF SENSITIZING CANCERS TO IMMUNOTHERAPY USING IMMUNOMODULATORY AGENTS | The Regents of the University of California | REYNOLDS, FRED H | 1658 | §102§103§112 | Final Rejection | 16d | Pending | May 08, 2023 |
| 18137022 | METHODS AND COMPOSITIONS FOR CONTROL OF ARTHROPOD PESTS | Greenlight Biosciences, Inc. | HUDSON, AMY ROSE | 1636 | §103§112 | Final Rejection | — | Pending | Apr 20, 2023 |
| 18028937 | CANNABIS PLANT DERIVED EXTRACELLULAR VESICLES AND THERAPEUTIC METHODS USING THE SAME | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | LEE, SIN J | 1613 | §103§112 | Final Rejection | — | Pending | Mar 28, 2023 |
| 18125949 | TREATMENT OF AQUEOUS SYSTEMS | Mfg Chemical, LLC | GEISBERT, WILLIAM ADDISON | 1779 | §103§112 | Non-Final OA | — | Pending | Mar 24, 2023 |
| 18178192 | AGENTS FOR THE TREATMENT OF DISEASES BY INHIBITION OF FOXO1 | The Trustees of Columbia University in the City of New York | FETTEROLF, BRANDON J | 1626 | §102§103§112 | Non-Final OA | 56d overdue | Pending | Mar 03, 2023 |
| 18024444 | PHARMACEUTICAL COMPOSITION USEFUL FOR PROMOTING OSTEOBLASTOGENESIS | BIOCODEX | BOECKELMAN, JACOB A | 1655 | §103 | Non-Final OA | — | Pending | Mar 02, 2023 |
| 18021884 | USE OF FANA ANTISENSE OLIGONUCLEOTIDES FOR THE PREVENTION AND MANAGEMENT OF HUANGLONGBING AND ZEBRA CHIP DISEASES | Aum Lifetech, Inc. | CHATTERJEE, JAYANTA | 1662 | §103§112Other | Non-Final OA | 53d overdue | Pending | Feb 17, 2023 |
| 17911789 | METHODS OF TREATING VIRAL INFECTIONS AND HEALTH CONSEQUENCES | Allen Davidoff | ROBINSON, HOPE A | 1652 | §112 | Non-Final OA | — | Pending | Sep 15, 2022 |
| 17911026 | METHODS, DEVICES, AND COMPOSITIONS FOR LESION REPAIR AND PREVENTION | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | NGUYEN, NGOC-ANH THI | 1615 | §103 | Non-Final OA | — | Pending | Sep 12, 2022 |
| 17818159 | XANTHINE OXIDASE INHIBITOR FORMULATIONS | Xortx Therapeutics, Inc. | HUANG, GIGI GEORGIANA | 1613 | §101§102§103§112Other | Final Rejection | 14d | Pending | Aug 08, 2022 |
| 17614076 | METHOD FOR PREPARING PHARMACEUTICAL COMPOSITIONS CONTAINING AMPHIPHILIC ACTIVE INGREDIENTS | Pharmadev SA | MERCIER, MELISSA S | 1615 | §102§103 | Final Rejection | 21d | Pending | Jul 11, 2022 |
| 17774215 | METHODS FOR DISTINGUISHING THE STAGES OF BACTERIAL VAGINOSIS | UNIVERSITY OF MARYLAND, BALTIMORE | MCKNIGHT, CIARA A | 1656 | §101§103 | Non-Final OA | 19d | Pending | May 04, 2022 |
| 17615894 | A COOLING PREPARATION | Symrise AG | BERRIOS, JENNIFER A | 1613 | §103 | Final Rejection | — | Pending | Dec 02, 2021 |
| 17490268 | METHOD FOR OPERATING HEALTH-CARE DEVICE | Tao Mining Co., Ltd. | NEMER, OSAMA MOHAMMAD | 3771 | §103 | Final Rejection | 4d overdue | Pending | Sep 30, 2021 |
| 17598695 | SELECTIVE FOXO INHIBITORS FOR TREATMENT OF DIABETES AND OTHER DISORDERS RELATED TO IMPAIRED PANCREATIC FUNCTION | The Trustees Of Columbia Universityin The City Of New York | ROMERO, KRISTEN WANG | 1624 | §102Other | Non-Final OA | 73d overdue | Pending | Sep 27, 2021 |
| 17478015 | COMPOSITIONS AND METHODS FOR CONTROLLING INSECT PESTS | Greenlight Biosciences, Inc. | ZHENG, LI | 1662 | §112 | Non-Final OA | 70d overdue | Pending | Sep 17, 2021 |
| 17432177 | LIF THERAPY FOR INDUCING INTESTINAL EPITHELIAL CELL REGENERATION | Rutgers, The State University Of New Jersey | XIE, XIAOZHEN | 1674 | §103§112 | Final Rejection | 12d | Pending | Aug 19, 2021 |
| 17370759 | IDENTIFYING TRANSITION POINTS IN CHEMICAL REACTIONS | Azure Vault Ltd. | MINCHELLA, KAITLYN L | 1685 | §101§112Other | Non-Final OA | 1d overdue | Pending | Jul 08, 2021 |
| 17325839 | RAPID DIAGNOSTIC SYSTEM USING TARGETED ANTISENSE OLIGONUCLEOTIDE CAPPED PLASMONIC NANOPARTICLES | UNIVERSITY OF MARYLAND, BALTIMORE | SITTON, JEHANNE SOUAYA | 1682 | §103 | Non-Final OA | — | Pending | May 20, 2021 |
| 17161641 | COMPOSITIONS AND METHODS FOR CONTROLLING ARTHROPOD PARASITE AND PEST INFESTATIONS | Greenlight Biosciences, Inc. | TRAN, CHRISTINA L | 1637 | DPOther | Non-Final OA | — | Pending | Jan 28, 2021 |
| 16813263 | Methods of Generating Mature Human Muscle Fibers | UNIVERSITY OF MARYLAND, BALTIMORE | POPA, ILEANA | 1633 | §103Other | Non-Final OA | 89d overdue | Pending | Mar 09, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial